Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Up 80.0% in June

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWMGet Free Report) was the recipient of a significant growth in short interest in June. As of June 15th, there was short interest totalling 900 shares, a growth of 80.0% from the May 31st total of 500 shares. Based on an average daily volume of 4,200 shares, the short-interest ratio is currently 0.2 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Stock Performance

HROWM remained flat at $26.72 during trading on Friday. The company had a trading volume of 1,320 shares, compared to its average volume of 3,981. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 52-week low of $22.71 and a 52-week high of $27.72. The firm’s fifty day moving average price is $26.34 and its 200-day moving average price is $26.12.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, April 30th. Investors of record on Monday, April 15th were issued a $0.7422 dividend. The ex-dividend date of this dividend was Friday, April 12th. This represents a $2.97 dividend on an annualized basis and a yield of 11.11%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

(Get Free Report)

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.

See Also

Receive News & Ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Harrow Health Inc. 11.875% Senior Notes due 2027 and related companies with MarketBeat.com's FREE daily email newsletter.